Singleron Biotechnologies GmbH

Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking single cell analysis techniques in clinical diagnosis, drug development, and health management. Singleron Biotechnologies is an innovative and rapidly growing company providing complete solutions for single-cell sequencing technologies. To improve clinical diagnosis, drug development, and health management, Singleron brings breakthrough single-cell analysis techniques to clinicans and researchers. The company was incorporated in January 2018 and currently has offices, laboratories, and manufacturing facilities in Cologne, Germany, Nanjing and Suzhou in China, and New Haven, CT, USA. Singleron obtained a worldwide exclusive IP license from Yale University for its uniquely designed microfluidic single-cell processing device, and has developed the GEXSCOPE® single cell system based on this microfluidic device.